Modeling hematopoietic transplantation with ES cells

May 2004
Molecular Therapy;May2004 Supplement 1, Vol. 9, p353
Academic Journal
An abstract of the article "Modeling Hematopoietic Transplantation with ES Cells," by George Q. Daley is presented.


Related Articles

  • Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells. Wai Feng Lim; Tomoko Inoue-Yokoo; Keai Sinn Tan; Lai, Mei I.; Daisuke Sugiyama // Stem Cell Research & Therapy;2013, Vol. 4 Issue 3, p1 

    Pluripotent stem cells, both embryonic stem cells and induced pluripotent stem cells, are undifferentiated cells that can self-renew and potentially differentiate into all hematopoietic lineages, such as hematopoietic stem cells (HSCs), hematopoietic progenitor cells and mature hematopoietic...

  • F4/80+ Host Macrophages Are a Barrier to Murine Embryonic Stem Cell-Derived Hematopoietic Progenitor Engraftment . Thompson, Heather L.; van Rooijen, Nico; McLelland, Bryce T.; Manilay, Jennifer O. // Journal of Immunology Research;10/30/2016, p2414906 

    Understanding how embryonic stem cells and their derivatives interact with the adult host immune system is critical to developing their therapeutic potential. Murine embryonic stem cell-derived hematopoietic progenitors (ESHPs) were generated via coculture with the bone marrow stromal cell line,...

  • Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Anderson, Joseph S.; Bandi, Sriram; Kaufman, Dan S.; Akkina, Ramesh // Retrovirology;2006, Vol. 3, p24 

    Background: Many novel studies and therapies are possible with the use of human embryonic stem cells (hES cells) and their differentiated cell progeny. The hES cell derived CD34 hematopoietic stem cells can be potentially used for many gene therapy applications. Here we evaluated the capacity of...

  • Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. Ratcliffe, Elizabeth; Glen, Katie E.; Naing, May Win; Williams, David J. // British Medical Bulletin;Dec2013, Vol. 108 Issue 1, p73 

    Background Apart from haematopoietic stem cell transplantation for haematological disorders many stem cell-based therapies are experimental. However, with only 12 years between human embryonic stem cell isolation and the first clinical trial, development of stem cell products for regenerative...

  • Stem Cells in Dentistry-A Revolution in Regeneration. Reddy, Ramesh; Babu, Mahesh; Reddy, V. Sasidhar; Gautham, P. // Medico-Legal Update;Jan-Jun2012, Vol. 12 Issue 1, p73 

    The article discusses the factors involved for the successful practical use of stem cell research in dentistry. It traces the history of stem cell research. The sources of stem cells includes bone marrow, blood left over in the umbilical cord and placenta of a newborn child. The two major...

  • Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Gea-Banacloche, J; Masur, H; da Cunha, C Arns; Chiller, T; Kirchhoff, L V; Shaw, P; Tomblyn, M; Cordonnier, C // Bone Marrow Transplantation;Apr2010, Vol. 45 Issue 4, p806 

    A correction to the article "Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective" that was published in 2009 issue is presented.

  • Recipient seropositivity for adenovirus type 11 (AdV11) is a highly predictive factor for the development of AdV11-induced hemorrhagic cystitis after allogeneic hematopoietic SCT. Nakazawa, Y; Saito, S; Yanagisawa, R; Suzuki, T; Ito, T; Ishida, F; Muramatsu, H; Matsumoto, K; Kato, K; Ishida, H; Umeda, K; Adachi, S; Nakahata, T; Koike, K // Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p737 

    A letter to the editor is presented which discusses the seropositivity of recipients of allogeneic hematopoietic stem cells transplantation (HSCT) for adenovirus type 11 (AdV11).

  • High Morbidity Burden Borne Years Later by Survivors of Transplant. Helwick, Caroline // American Health & Drug Benefits;Feb Special Issue 2012, Vol. 5, p22 

    The article discusses research on hematopoietic cell transplant which was reported at a 2012 press conference by Stephanie J. Lee of the University of Washington School of Medicine in Seattle, Washington. The research found that while the transplants may cure many hematologic malignancies...

  • Hematopoietic stem cells for transplantation. Verfaillie, Catherine M. // Nature Immunology;Apr2002, Vol. 3 Issue 4, p314 

    Discusses the engraftment capabilities of hematopoietic stem cell sources. HSC characteristics; Ontogenic differences in HSCs; Frequency of human HSCs in fluorescence-activated cell sort-selected CD34.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics